Durable Protection from Vaginal Simian-Human Immunodeficiency Virus Infection in Macaques by Tenofovir Gel and Its Relationship to Drug Levels in Tissue-Reference-Cited by-同舟云学术

Durable Protection from Vaginal Simian-Human Immunodeficiency Virus Infection in Macaques by Tenofovir Gel and Its Relationship to Drug Levels in Tissue

Published:2011-11-09 Issue:2 Volume:86 Page:718-725
ISSN:0022-538X
Container-title:Journal of Virology
language:en
Short-container-title:Journal of Virology

Author:

Dobard C.,Sharma S.,Martin A.,Pau C.-P.,Holder A.,Kuklenyik Z.,Lipscomb J.,Hanson D. L.,Smith J.,Novembre F. J.,Garcia-Lerma J. G.,Heneine W.

Publisher

American Society for Microbiology

Subject

Virology,Insect Science,Immunology,Microbiology

Reference40 articles.

1. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women;Abdool Karim;Science,2010

2. Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies;Atashili;AIDS,2008

3. Antiretroviral drug exposure in the female genital tract: implications for oral pre- and post-exposure prophylaxis;Dumond;AIDS,2007

4. Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir;García-Lerma;PLoS Med.,2008

5. Intermittent prophylaxis with oral truvada protects macaques from rectal SHIV infection;Garcia-Lerma;Sci. Transl. Med.,2010

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Phase 1 Clinical Trial to Assess the Safety and Pharmacokinetics of a Tenofovir Alafenamide/Elvitegravir Insert Administered Rectally for HIV Prevention;The Journal of Infectious Diseases;2024-04-24

2. Preclinical and Early Clinical Development of Tenofovir Alafenamide/Elvitegravir Topical Inserts for Effective On-Demand Vaginal and Rectal HIV Prevention;Pharmaceutics;2024-03-01

3. Phase 1 randomized pharmacokinetic and safety study of a 90‐day tenofovir vaginal ring in the United States;Journal of the International AIDS Society;2024-03

4. A phase I study to assess safety, pharmacokinetics, and pharmacodynamics of a vaginal insert containing tenofovir alafenamide and elvitegravir;Frontiers in Cellular and Infection Microbiology;2023-04-19

5. Pharmacokinetics and efficacy of topical inserts containing tenofovir alafenamide fumarate and elvitegravir administered rectally in macaques;eBioMedicine;2022-12